NCT03628911 is a NA clinical trial of Tetanizing Burst Therapy in Cardiac Electrophysiology, sponsored by EP Sciences.

Who is sponsoring NCT03628911?

NCT03628911 is sponsored by EP Sciences.

What drugs are being tested in NCT03628911?

Interventions in NCT03628911: Tetanizing Burst Therapy.

What condition does NCT03628911 study?

NCT03628911 studies Cardiac Electrophysiology.

Is NCT03628911 still recruiting?

NCT03628911 is currently status unknown. Last updated 17 September 2019.

Last reviewed 2019-09-17 · How we verify

NCT03628911

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study to Evaluate Tetanizing Burst Therapy in Patients Undergoing ICD Replacement

Status unknown NA Last updated 17 September 2019

What this trial tests

NA trial testing Tetanizing Burst Therapy in Cardiac Electrophysiology in 50 participants. Status unknown.

Timeline

1 January 2018

Primary endpoint
1 September 2020

1 December 2020

Quick facts

Lead sponsor	EP Sciences
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	1 January 2018
Primary completion	1 September 2020
Estimated completion	1 December 2020
Sites	1 location across United States

Drugs / interventions tested

Tetanizing Burst Therapy

Conditions studied

Cardiac Electrophysiology — all drugs for Cardiac Electrophysiology →

Sponsor

EP Sciences

Who can join

Adults 18 to 80, any sex, with Cardiac Electrophysiology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates whether the addition of tetanizing burst therapy reduces the pain associated with ICD shocks

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03628911 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by EP Sciences
Last refreshed: 17 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03628911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing